New skin test for tuberculosis in people 3 and older
Part of Infections clinical trials.
This trial tests a new skin test (EEC) to see if it can accurately detect tuberculosis infection in people aged 3 and older. It compares the test's results in healthy people, people with TB, and people with other lung diseases to check how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 3 years old.
- You should not have a current or past tuberculosis (TB) infection (or symptoms of TB).
- You must not have a weakened immune system or be taking medicines that weaken immunity (like high-dose steroids).
- You cannot have an active infection, severe skin condition, or be pregnant or breastfeeding.
- You must not have had certain vaccines within the past 7 to 28 days.
- You must be able to attend follow-up visits and understand the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter treatment regimen for people with tuberculosis (TB) who don't have symptoms. If you have TB bacteria in your lungs but no cough, fever, night sweats, or weight loss, this study may offer a more convenient treatment option.
This study is testing a new blood test (IGRA) to see if it can help doctors diagnose active and latent (hidden) tuberculosis. If you are already being treated for TB and have had an IGRA blood test, you may be able to join.
This study looks at how the immune system reacts in people with tuberculosis (TB), their close contacts, people with other lung diseases, and healthy volunteers. It aims to find better ways to diagnose and manage TB.
This study tests new, faster ways to detect tuberculosis (TB) using phlegm, tongue swabs, or urine. It aims to find a simpler and more accurate test than current ones, which could help you get the right treatment sooner.
This early-phase trial tests a new vaccine designed to prevent tuberculosis (TB). It helps researchers see if the vaccine is safe and produces an immune response in healthy adults. Participation may contribute to the development of a new prevention tool for TB.
This trial tests a new “triple-dose” set of medicines to treat people whose tuberculosis (TB) has come back in the lungs. If you qualify, the goal is to improve cure rates and reduce the chance of TB returning again.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.